Bone marrow-derived mesenchymal stem cells in repair of the injured lung.

By M. Rojas, Jianguo Xu, C. Woods, A. Mora, W. Spears, J. Roman, K. Brigham. American Journal of Respiratory Cell and Molecular Biology, 2005

847 citations recorded by the source corpus.

Subfields: Biomaterials, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/c971d02999eecde9373eb5a0bbf6337db608337f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. A. Caplan

In Genetics

1. Michael A. Matthay
2. A. Caplan
3. L. Meirelles
4. R. Zemans

In Surgery

1. A. Caplan
2. Michael A. Matthay

Citations in the corpus

• Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 (2007, background): “Recent studies have demonstrated that bone marrow-derived mesenchymal stem cells (MSC) have the ability to participate in the repair of experimental models of bleomycin-induced lung injury (3, 4).”
• Mechanisms involved in the therapeutic properties of mesenchymal stem cells. (2009, background): “In an in vitro assay, murine MSCs migrated toward cells isolated from bleomycin-injured mouse lungs, but not toward healthy lung cells [46].”
• The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? (2008, positive): “15 5 BMD MSC early (Rojas et al., 2005)”